<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/1995-1191-2020-2-72-79</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-1186</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая трансплантология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical Transplantology</subject></subj-group></article-categories><title-group><article-title>Электрокинетические, оксидантные и агрегационные свойства эритроцитов в послеоперационном периоде при трансплантации почки</article-title><trans-title-group xml:lang="en"><trans-title>Electrokinetic, oxidative and aggregation properties of red blood cells in the postoperative period following kidney transplantation</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дерюгина</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Deryugina</surname><given-names>A. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абаева</surname><given-names>О. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Abaeva</surname><given-names>O. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Абаева Ольга Петровна</p><p>Адрес: 603001, Нижний Новгород, Нижне-Волжская наб., д. 2. Тел. (910) 792-55-07. </p></bio><bio xml:lang="en"><p>Olga Abaeva</p><p>Address: 2, Nizhne-Volgskaya nab., Nizhny Novgorod, 603001. Теl. (910) 792-55-07.</p><p>аbaevaop@inbox.ru</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Романов</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Romanov</surname><given-names>S. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ведунова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vedunova</surname><given-names>M. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рябова</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Ryabova</surname><given-names>E. N.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васенин</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasenin</surname><given-names>S. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Титова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Titova</surname><given-names>N. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Национальный исследовательский Нижегородский государственный университет имени Н.И. Лобачевского»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Lobachevsky University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России (Сеченовский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАОУ ВО «Национальный исследовательский Нижегородский государственный университет имени Н.И. Лобачевского»; &#13;
ФБУЗ «Приволжский окружной медицинский центр» ФМБА России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Lobachevsky University; &#13;
Volga Regional Medical Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФБУЗ «Приволжский окружной медицинский центр» ФМБА России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Volga Regional Medical Center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>12</day><month>07</month><year>2020</year></pub-date><volume>22</volume><issue>2</issue><fpage>72</fpage><lpage>79</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Дерюгина А.В., Абаева О.П., Романов С.В., Ведунова М.В., Рябова Е.Н., Васенин С.А., Титова Н.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Дерюгина А.В., Абаева О.П., Романов С.В., Ведунова М.В., Рябова Е.Н., Васенин С.А., Титова Н.А.</copyright-holder><copyright-holder xml:lang="en">Deryugina A.V., Abaeva O.P., Romanov S.V., Vedunova M.V., Ryabova E.N., Vasenin S.A., Titova N.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/1186">https://journal.transpl.ru/vtio/article/view/1186</self-uri><abstract><p>Цель. Исследование электрокинетических, агрегационных свойств, про- и антиоксидантных процессов в эритроцитах после трансплантации почки у доноров и в постоперационный период у реципиентов. Материалы исследования. Кровь 12 реципиентов и 5 доноров почки во временной динамике – до операции, через 1 неделю, 1, 2, 7, 10, 12 месяцев после операции, а также 8 здоровых добровольцев, составивших группу контроля. Методы исследования. Электрофоретическую подвижность эритроцитов, характеризующую электрокинетические свойства клеток, измеряли методом микроэлектрофореза. Агрегацию рассчитывали микроскопически, путем подсчета неагрегированных эритроцитов. Концентрацию малонового диальдегида в эритроцитах определяли спектрофотометрически по максимуму поглощения при 530 нм при реакции с тиобарбитуровой кислотой. Активность каталазы анализировали по снижению пероксида водорода в пробе спектрофотометрически при длине волны 240 нм. Сравнение полученных величин проводили по U-критерию Манна–Уитни. Результаты. Показано, что снижение электрофоретической подвижности эритроцитов в течение 2 месяцев после трансплантации сочеталось с увеличением концентрации малонового диальдегида и агрегации эритроцитов, уменьшением активности каталазы у реципиентов почки с последующим восстановлением показателей до значений контрольной группы. У доноров после операции выявлено снижение электрофоретической подвижности эритроцитов и увеличение концентрации малонового диальдегида в эритроцитах, но менее выраженное по сравнению с реципиентами. Выявленные изменения свидетельствуют, что постоперационный период как у доноров, так и у реципиентов вызывает изменения на клеточном уровне, что проявляется понижением стабильности структуры мембраны эритроцитов, которая во многом определяется процессами перекисного окисления липидов. На системном уровне изменение электрофоретической подвижности эритроцитов свидетельствует о развитии стрессреакции до и после трансплантации почки у реципиентов в течение 2 месяцев после операции, у доноров на 1–2-й месяц в постоперационный период с постепенным повышением резистентности организма. Заключение. Трансплантация почки проявляется на клеточном и на системном уровнях. На клеточном уровне понижением стабильности структуры мембраны, которая во многом определяется процессами перекисного окисления липидов. На системном уровне изменение электрофоретической подвижности эритроцитов свидетельствует о развитии стресс-реакции с постепенным повышением резистентности организма. Полученные данные свидетельствуют об изменениях функциональных свойств эритроцитов при трансплантации почки у реципиентов, а также у доноров, что необходимо учитывать при проведении терапевтических мероприятий.</p></abstract><trans-abstract xml:lang="en"><p>Objective: to study the electrokinetic and aggregation properties, as well as the pro-oxidant and antioxidant processes in red blood cells following kidney transplantation in donors and in recipients in the postoperative period. Materials and methods. Blood from 12 recipients and 5 kidney donors over time – before transplantation, as well as at week 1, months 1, 2, 7, 10 and 12 after surgery, as well as from 8 healthy volunteers who formed the control group. We used microelectrophoresis to measure the electrophoretic mobility of red blood cells, characterizing the electrokinetic properties of cells. Aggregation was calculated microscopically by counting unaggregated red blood cells. Malondialdehyde concentration was measured spectrophotometrically at its absorbance maximum at 530 nm by reaction with thiobarbituric acid. Catalase activity was analyzed by reducing hydrogen peroxide in the sample spectrophotometrically at 240 nm wavelength. The obtained values were compared using the Mann–Whitney U test. Results. Decreased electrophoretic mobility of red blood cells within 2 months after transplantation was associated with increased malondialdehyde concentration and erythrocyte aggregation, decreased catalase activity in kidney recipients, followed by restoration of indicators to the control values. Electrophoretic mobility of red blood cells decreased, while malondialdehyde concentrations increased in donors after surgery. However, the increase was less pronounced than in recipients. The changes indicate that the postoperative period causes changes at the cellular level both in donors and in recipients. This is manifested by decreased stability of erythrocyte membrane structure, which is largely determined by lipid peroxidation processes. At the systemic level, a change in the electrophoretic mobility of red blood cells indicates a stress reaction before and after kidney transplantation in recipients within 2 months after surgery, and in donors in 1–2 months in the postoperative period with gradual increase in the body’s resistance. Conclusion. Kidney transplantation is manifested at the cellular and systemic levels. At the cellular level, there is decreased stability of the membrane structure, which is largely determined by lipid peroxidation processes. At the systemic level, a change in the electrophoretic mobility of red blood cells indicates a stress reaction with gradual increase in the body’s resistance. The data obtained demonstrate changes in the functional properties of red blood cells both in kidney transplant recipients and in donors. These changes need to be taken into account when carrying out therapeutic measures.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>трансплантация почки</kwd><kwd>эритроциты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>kidney transplantation</kwd><kwd>red blood cells</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sayegh MH, Carpenter CB. Transplantation 50 years later – progress, challenges, and promises. The New England Journal of Medicine. 2004; 351 (26): 2761–2766. doi: 10.1056/NEJMon043418.</mixed-citation><mixed-citation xml:lang="en">Sayegh MH, Carpenter CB. Transplantation 50 years later – progress, challenges, and promises. The New England Journal of Medicine. 2004; 351 (26): 2761–2766. doi: 10.1056/NEJMon043418.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kiyokazu Akioka, Sirou Takahara, Seiji Ichikawa, Norio Yoshimura, Takahiro Akiyama, Shinichi Ohshima. Factors predicting long-term graft survival after kidney transplantation: multicenter study in Japan. World Journal of Surgery. 2005; 29 (2): 249–256. doi: 10.1007/s00268-005-7531-8.</mixed-citation><mixed-citation xml:lang="en">Kiyokazu Akioka, Sirou Takahara, Seiji Ichikawa, Norio Yoshimura, Takahiro Akiyama, Shinichi Ohshima. Factors predicting long-term graft survival after kidney transplantation: multicenter study in Japan. World Journal of Surgery. 2005; 29 (2): 249–256. doi: 10.1007/s00268-005-7531-8.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Столяр АГ. Влияние анемии на результаты трансплантации почки. Клиническая медицина. 2015; 93 (12): 24–27.</mixed-citation><mixed-citation xml:lang="en">Stolyar AG. Effect of anemia on the results of kidney transplantation. Clinical medicine (Russian Journal). 2015; 93 (12): 24–27. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Roufosse C, Simmonds N, Clahsen-van Groningen M, Haas M, Henriksen KJ, Horsfield C et al. Reference Guide to the Banff Classification of Renal Allograft Pathology. Transplantation. 2018; 102 (11): 1795–1814. doi: 10.1097/TP.0000000000002366.</mixed-citation><mixed-citation xml:lang="en">Roufosse C, Simmonds N, Clahsen-van Groningen M, Haas M, Henriksen KJ, Horsfield C et al. Reference Guide to the Banff Classification of Renal Allograft Pathology. Transplantation. 2018; 102 (11): 1795–1814. doi: 10.1097/TP.0000000000002366.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell P. Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation. Current opinion in organ transplantation. 2013; 18 (4): 463–469. doi: 10.1097/MOT.0b013e3283636c71.</mixed-citation><mixed-citation xml:lang="en">Campbell P. Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation. Current opinion in organ transplantation. 2013; 18 (4): 463–469. doi: 10.1097/MOT.0b013e3283636c71.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Vanrenterghem Y. Anaemia after renal transplantation. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association. 2004; 19 (5): 54–58. doi: 10.1093/ndt/gfh1057.</mixed-citation><mixed-citation xml:lang="en">Vanrenterghem Y. Anaemia after renal transplantation. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association. 2004; 19 (5): 54–58. doi: 10.1093/ndt/gfh1057.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Molnar MZ, Czira M, Ambrus C, Szeifert L, Szentkiralyi A, Beko G et al. Anemia is associated with mortality in kidney-transplanted patients. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association. 2007; 7 (4): 818–824. doi: 10.1093/ndt/gfh1057.</mixed-citation><mixed-citation xml:lang="en">Molnar MZ, Czira M, Ambrus C, Szeifert L, Szentkiralyi A, Beko G et al. Anemia is associated with mortality in kidney-transplanted patients. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association. 2007; 7 (4): 818–824. doi: 10.1093/ndt/gfh1057.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ватазин АВ, Зулькарнаев АБ. Трансплантация почки как оптимальный метод лечения хронической болезни почек. Лечебное дело. 2013; 3: 47–52.</mixed-citation><mixed-citation xml:lang="en">Vatazin AV, Zulkarnaev AB. Kidney Transplantation as an Optimal Treatment for Chronic Kidney Disease. The Journal of General Medicine. 2013; 3: 47–52. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Robertson AJ, Nargund V, Grey DW, Morris PJ. Low dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipients. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association. 2000; 15 (11): 1865–1868. doi: 10.1093/ndt/15.11.1865.</mixed-citation><mixed-citation xml:lang="en">Robertson AJ, Nargund V, Grey DW, Morris PJ. Low dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipients. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association. 2000; 15 (11): 1865–1868. doi: 10.1093/ndt/15.11.1865.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gnjatic S, Wheeler C, Ebner M, Ritter E, Murray A, Altorki NK et al. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays. Journal of Immunological Methods. 2009; 1–2 (341): 50–58. doi: 10.1016/j.jim.2008.10.016. Epub 2008 Nov 28.</mixed-citation><mixed-citation xml:lang="en">Gnjatic S, Wheeler C, Ebner M, Ritter E, Murray A, Altorki NK et al. Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays. Journal of Immunological Methods. 2009; 1–2 (341): 50–58. doi: 10.1016/j.jim.2008.10.016. Epub 2008 Nov 28.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Colvin MM, Cook JL, Chang P, Francis G, Hsu DT, Kiernan MS et al. Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management. Circulation. 2015; 18 (131): 1608– 1639. doi: 10.1161/CIR.0000000000000093.</mixed-citation><mixed-citation xml:lang="en">Colvin MM, Cook JL, Chang P, Francis G, Hsu DT, Kiernan MS et al. Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management. Circulation. 2015; 18 (131): 1608– 1639. doi: 10.1161/CIR.0000000000000093.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">An C, Akankwasa G, Liu J, Wang D, Cheng G, Zhang J et al. Urine markers of renal tubular injury in idiopathic membranous nephropathy: A cross sectional study. Clinica chimica acta; international journal of clinical chemistry. 2019; 492: 7–11. doi: 10.1016/j.cca.2019.01.015.</mixed-citation><mixed-citation xml:lang="en">An C, Akankwasa G, Liu J, Wang D, Cheng G, Zhang J et al. Urine markers of renal tubular injury in idiopathic membranous nephropathy: A cross sectional study. Clinica chimica acta; international journal of clinical chemistry. 2019; 492: 7–11. doi: 10.1016/j.cca.2019.01.015.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Беляков НА, Семесько СГ. Антиоксидантная активность биологических жидкостей человека: методология и клиническое значение. Эфферентная терапия. 2005; 11 (1): 5–21.</mixed-citation><mixed-citation xml:lang="en">Belyakov NA, Semesko SG. Antioxidant activity of human biological fluids: methodology and clinical value. Efferentnaya terapiya. 2005; 11 (1): 5–21. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Лобанова НА, Боровков НН. Спорные вопросы влияния уремической интоксикации и свободнорадикальных процессов на развитие у больных анемии при терминальной стадии хронической почечной недостаточности. Медицинский альманах. 2010; 3 (12): 152–155.</mixed-citation><mixed-citation xml:lang="en">Lobanova NA, Borovkov NN. The disputable issues of influence of uraemic intoxication and free-radical processes on the development of anaemia of patients at terminal stage of chronic renal insufficiency. Medical Almanac. 2010; 3 (12): 152–155. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ватазин АВ, Зулькарнаев АБ, Кантария РО, Артемов ДВ. Гуморальные факторы патогенеза ишемии/ реперфузии при трансплантации почки. Уральский медицинский журнал. 2012; 13 (105): 94–97.</mixed-citation><mixed-citation xml:lang="en">Vatazin AV, Zulkarnaev AB, Kantaria RO, Artemov DV. Humoral pathogenesis ischemia/reperfusion injury factors in renal transplantation. Ural’skij medicinskij zhurnal. 2012; 13 (105): 94–97. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Романов СВ, Абаева ОП, Александрова ОЮ, Смирнова ГЮ. Проблемы и перспективы построения системы органного донорства в регионе (на примере Нижегородской области). Вестник трансплантологии и искусственных органов. 2019; 21 (1): 57–63.</mixed-citation><mixed-citation xml:lang="en">Romanov  SV, Abaeva OP, Alexandrova OYu, Smirnova GYu. Issues and perspectives of building a regional system of donor services (on the example of Nizhny Novgorod region). Russian Journal of Transplantology and Artificial Organs. 2019; 21 (1): 57–63. doi: 10.15825/1995-1191-2019-1-57-63. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Boyarinov GA, Yakovleva EI, Zaitsev RR, Bugrova ML, Boyarinova LV, Solov’eva OD et al. Pharmacological Correction of Microcirculation in Rats Suffering from Traumatic Brain Injury. Cell and Tissue Biology. 2017; 11 (1): 65–72. doi: 10.1134/S1990519X17010023.</mixed-citation><mixed-citation xml:lang="en">Boyarinov GA, Yakovleva EI, Zaitsev RR, Bugrova ML, Boyarinova LV, Solov’eva OD et al. Pharmacological Correction of Microcirculation in Rats Suffering from Traumatic Brain Injury. Cell and Tissue Biology. 2017; 11 (1): 65–72. doi: 10.1134/S1990519X17010023.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Дерюгина АВ, Шумилова АВ. Влияние цитофлавина на окислительный стресс и активность NА/К-атфазы эритроцитов в посттравматический период черепномозговой травмы. Журнал неврологии и психиатрии. 2017; 11: 51–55.</mixed-citation><mixed-citation xml:lang="en">Deriugina AV, Shumilova AV. An influence of cytoflavin on oxidative stress and activity of Na/K-ATPase of erythrocytes after brain trauma. Neuroscience and Behavioral Physiology. 2017; 11: 51–55. doi: 10.17116/jnevro201711711151-55. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Козинец ГИ, Попова ОВ, Будник МИ, Шмаров ДА, Погорелов ВМ, Проценко ДД. Электрический заряд клеток крови. М.: Практическая медицина, 2007; 208.</mixed-citation><mixed-citation xml:lang="en">Kozinec GI, Popova OV, Budnik MI, Shmarov DA, Pogorelov VM, Procenko DD. Elektricheskij zaryad kletok krovi. M.: Prakticheskaya medicina, 2007; 208.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Крылов ВН, Дерюгина АВ, Плескова СН. Электрофоретическая подвижность и морфометрия эритроцитов крыс при стрессовых воздействиях. Современные технологии в медицине. 2010; 4: 23–26.</mixed-citation><mixed-citation xml:lang="en">Krylov VN, Deryugina AV, Pleskova SN. Electrophoretic mobility and morphometry of the rat erythrocytes at the stress effects. Sovremennye tehnologii v medicine. 2010; 4: 23–26. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Дерюгина АВ, Мартусевич АА, Веселова ТА. Молекулярно-клеточные механизмы реализации стрессреакции организма. Известия Уфимского научного центра Российской академии наук. 2015; 3: 58–63.</mixed-citation><mixed-citation xml:lang="en">Deryugina AV, Martusevich AA, Veselova TA. Molecular and cellular mechanisms of stress response realization in the organism. Izvestiya Ufimskogo nauchnogo centra Rossijskoj Akademii nauk. 2015; 3: 58–63. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Алясова АВ, Терентьев ИГ, Цыбусов СН, Ведунова МВ, Мищенко ТА, Шахова КА и др. Новые представления о механизмах действия доксорубицина и озона на злокачественные клетки печени. Современные технологии в медицине. 2017; 9 (2): 145–149.</mixed-citation><mixed-citation xml:lang="en">Аlyasova АV, Terentiev IG, Tsybusov SN, Vedunova МV, Мishchenko ТА, Shakhova KА et al. Novel notions of the mechanisms of action of doxorubicin and ozone on malignant hepatic cells. Sovremennye tehnologii v medicine 2017; 9 (2): 145–149. doi: 10.17691/stm2017.9.2.18. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Sprague R, Ellsworth M, Stephenson A, Kleinhenz M. Deformation-induced ATP release from red blood cells requires CFTR activity. American Physiological Society. 2010; 26 (2): 168–174.</mixed-citation><mixed-citation xml:lang="en">Sprague R, Ellsworth M, Stephenson A, Kleinhenz M. Deformation-induced ATP release from red blood cells requires CFTR activity. American Physiological Society. 2010; 26 (2): 168–174.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Бизенкова МН, Романцева МГ, Чеснокова НП. Метаболические эффекты антиоксидантов в условиях острой гипоксической гипоксии. Фундаментальные исследования. 2006; 1: 17–21.</mixed-citation><mixed-citation xml:lang="en">Bizenkova MN, Romantseva MG, Chesnokova NP. Metabolic effects of antioxidants in acute anoxic hepoxia. Fundamental research. 2006; 1: 17–21. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Гольдин ММ, Евсеев АК, Ельков АН, Пинчук АВ, Царькова ТГ. Разработка и оценка эффективности использования электрохимического прогностического критерия развития осложнений у пациентов после трансплантации почки. Трансплантология. 2015; 3: 6–10.</mixed-citation><mixed-citation xml:lang="en">Gol’din MM, Evseev AK, El’kov AN, Pinchuk AV, Tsar’kova TG. Development and efficacy evaluation of the electrochemical predictor of complications in patients after kidney transplantation. Transplantologiya. The Russian Journal of Transplantation. 2015; 3: 6–10. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Антипенко ЕА, Дерюгина АВ, Густов АВ. Влияние неспецифической цитопротективной терапии на стрессоустойчивость и компенсаторные возможности пациентов с хронической ишемией головного мозга. Журнал неврологии и психиатрии им. C.C. Корсакова. 2015; 115 (12): 74–78.</mixed-citation><mixed-citation xml:lang="en">Antipenko EA, Derugina AV, Gustov AV. An effect of cytoprotective therapy on stress resistance and compensatory abilities of patients with chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2015; 115 (12): 74–78. doi: 10.17116/jnevro201511511274-78. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Калий ВВ. Состояние синтеза и метаболизма глюкокортикоидных гормонов у больных раком гортани молодого возраста. Сибирский медицинский журнал. 2010; 25 (1): 15–16.</mixed-citation><mixed-citation xml:lang="en">Kalyi VV. Synthesis and metabolism of glucocorticoid hormones in patients of young age groups having laryngeal cancer. The Siberian Medical Journal. 2010; 25 (1): 15–16. [In Russ, English abstract].</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Сергеев ПВ. Стероидные гормоны. М.: Наука, 1984; 240.</mixed-citation><mixed-citation xml:lang="en">Sergeev P.V. Steroidnye gormony. M.: Nauka, 1984; 240.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
